Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,431,490
+$110,345 QoQ
Shares Held
11,140
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,825
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. MRK ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,076 | $3,689,446 | |
| 2 | JNJ |
Johnson & Johnson
|
9,737 | $2,472,905 | |
| 3 | AMGN |
Amgen Inc
|
4,049 | $1,466,223 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
11,140 | $1,431,490 | |
| 5 | ABBV |
AbbVie Inc.
|
4,882 | $1,228,506 | |
| 6 | NVS |
Novartis AG
|
5,542 | $868,542 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,306 | $536,211 | |
| 8 | GSK |
GSK plc
|
8,000 | $419,360 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,431,490 | 11,140 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,321,145 | 10,983 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,074,073 | 10,204 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $820,751 | 9,779 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $750,041 | 9,475 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $983,231 | 10,954 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,096,767 | 11,025 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $1,204,076 | 10,603 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,321,193 | 10,672 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,455,012 | 11,027 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,192,351 | 10,937 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,139,759 | 11,071 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,276,790 | 11,065 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,092,093 | 10,265 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,144,671 | 10,317 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $857,582 | 9,958 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $712,037 | 7,810 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $616,933 | 7,519 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $421,749 | 5,503 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $412,429 | 5,491 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $573,864 | 7,379 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $505,093 | 6,552 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $457,997 | 5,599 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $455,478 | 5,491 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $373,504 | 4,830 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $333,457 | 4,334 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||